Eda sells NVO 54.69: Emisphere's Undervalued Diabetes Pill Partnership Is An Oversized Opportunity
“With Eligen B12 having launched in March 2015 and prospects of its oral diabetes pill in collaboration with Novo Nordisk (NYSE:NVO) going to Phase 3, EMIS is beginning to transform its reputation. This article addresses EMIS’s potential valuation and …” said Robbie to Vicki on Wednesday, July 1, 2015.
“My dear Miss Vicki,” said Robbie, “have you heard that ESX went down to 149.9?”
“Sel Euro 50 Ndx.”
Vicki replied that she had not.
“But it did,” said Robbie. “EUR/USD suffers highest daily-loss in months as Greece, Fed hike weigh EUR/USD plummeted 0.0173 or 1.53% to 1.1168, experiencing its largest one-day sell-off on a percentage basis since March 19, when it tumbled 1.90%. At one point in Tuesday’s session, the euro plunged to … that there is a 50/50 chance lift-off could …”
Vicki, with thoughts that could rest on nothing, made no answer.